Cash Flow Statement

Amortization Amortization Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Working Capital Change in Working Capital Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued

Growth Metrics

Others

Avricore Health (AVCRF) Other financing activities (2020 - 2021)

Avricore Health has reported Other financing activities over the past 2 years, most recently at -$718.76 for Q4 2021.

Quarterly Other financing activities rose 96.11% to -$718.76 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$77903.5 through Dec 2021, changed N/A year-over-year, with the annual reading at -$78675.2 for FY2021, 317.54% down from the prior year.
Other financing activities was -$718.76 for Q4 2021 at Avricore Health, up from -$77184.8 in the prior quarter.
Over five years, Other financing activities peaked at -$718.76 in Q4 2021 and troughed at -$77184.8 in Q1 2021.